CTSOVSENLV• 12 Months (Normalized)
CTSO vs ENLV (Cytosorbents Corporation vs Enlivex Ltd.)
Showing Closing Date Range from Sep 25, 2025 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CTSO Performance $4.91
+%
Cytosorbents Corporation
Normalized Baseline0.00%
ENLV Performance $0.57
-96.29%
Enlivex Ltd.
Normalized Baseline0.00%
Alpha Spread Margin CTSO LEADS
+96.29 pts
CTSO outperforming by 96.29 percentage points
CTSOENLV
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CTSO ENLV
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(250 dates)
| Date | CTSO Price | CTSO Gain (%) | ENLV Price | ENLV Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 24, 2026 | $- | $0.57 | -96.29% | - | |
| Sep 23, 2026 | $4.91 | +430.24% | $0.64 | -95.86% | +526.10% |
| Sep 21, 2026 | $5.51 | +495.03% | $0.69 | -95.51% | +590.54% |
| Sep 18, 2026 | $5.75 | +520.95% | $0.81 | -94.78% | +615.73% |
| Sep 17, 2026 | $5.76 | +522.03% | $0.73 | -95.29% | +617.32% |
| Sep 16, 2026 | $5.73 | +518.79% | $0.81 | -94.75% | +613.54% |
| Sep 15, 2026 | $6.06 | +554.43% | $0.88 | -94.28% | +648.71% |
| Sep 14, 2026 | $6.07 | +555.51% | $0.86 | -94.40% | +649.91% |
| Sep 11, 2026 | $6.41 | +592.22% | $0.96 | -93.79% | +686.01% |
| Sep 10, 2026 | $6.37 | +587.90% | $0.98 | -93.65% | +681.55% |
| Sep 09, 2026 | $6.33 | +583.59% | $1.04 | -93.27% | +676.86% |
| Sep 08, 2026 | $- | $1.11 | -92.82% | - | |
| Sep 04, 2026 | $0.35 | -62.20% | $1.10 | -92.88% | +30.68% |
| Sep 03, 2026 | $0.35 | -62.20% | $1.16 | -92.49% | +30.29% |
| Sep 02, 2026 | $0.38 | -58.53% | $1.25 | -91.91% | +33.38% |
Page 1 of 17